Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-25 @ 2:11 AM
NCT ID:
NCT05708560
Eligibility Criteria:
Inclusion Criteria:
* Chronic hepatitis B monoinfection
* At least two liver stiffness measurements more than 6 months apart
* Availability of data on hepatic steatosis (ultrasound, controlled attenuation parameter or histology) within 1 year of baseline
Exclusion Criteria:
* antiviral therapy with drugs other than entecavir, tenofovir disoproxil fumarate or tenofovir alafenamide (for group 2 only)
* Presence of concomitant liver disease such as Wilson's disease, autoimmune hepatitis, hemochromatosis or alcohol abuse (\>21 alcoholic drinks/week, female's \>14/week)
* Presence of secondary causes of hepatic steatosis (medication, alcohol abuse)
* Coinfection with HCV, HIV, HEV
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05708560
Study Brief:
Protocol Section:
NCT05708560